Most Recent
Switzerland-based Biogen has sued generic drug maker MSN Laboratories for allegedly threatening to infringe the patent for its top-selling oral MS drug Tecfidera.
A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.
The ACCC has suffered a stinging defeat in its criminal cartel action against mobility equipment provider Country Care, its CEO and a former employee, with a jury handing down not guilty verdicts on all eight charges in the case.
A former executive of hospital operator Healthe Care Pty has pleaded guilty to one charge of insider trading for acquiring a large number of shares in Pulse Health while in possession of inside information about the private hospital operator.
Melbourne hospital operator Western Health is facing a potential class action by junior doctors alleging they have been denied overtime pay, the third underpayments class action to be filed by doctors in Victoria.
The former chief financial officer of delisted Traditional Therapy Clinics has been sentenced to one year and ten months in prison after pleading guilty to market manipulation charges relating to transactions intended to create an artificial share price for the traditional therapy clinic company.
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff's defect and negligence claims had a better chance of succeeding.
A former CEO of a global pharmaceutical company has lost his appeal of a ruling throwing out a lawsuit he brought against his former employer after he was terminated in the wake of accusations that he harassed staff and using a syringe to stab multiple employees.
The Australian Competition and Consumer Commission has dropped a consumer case accusing NIB Health Funds of failing to alert customers to coverage changes in their policies, less than a month before trial was set to kick off in the long-running case.
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.